GKB Ophthalmics balance sheet

As of Mar 2023

Total assets: ₹49.1cr
Shareholders' equity: ₹27.5cr
Total debt: ₹11.2cr
Cash and investments: ₹0.1cr

₹ crore except per share

Tap a line for its trend	FY23Mar 2023

Non-current assets
	17.3
	3.8
	0.0
	11.9
	0.1
	12.0
	2.4
	35.7
Current assets
	6.1
	0.0
	4.9
	0.1
	0.3
	1.7
	7.0
	0.4
	13.4
	49.1
Equity
	5.0
	22.5
	27.5
	27.5
Liabilities
	1.2
	1.0
	2.1
	1.9
	4.1
	10.0
	5.2
	1.5
	16.8
	0.4
	0.4
	17.6
	21.6
	49.1

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

GKB₹60.01

GKB Ophthalmics Limited

· Pharma & Health

₹ CrorePeersFABTECH LAXMIDENTL TARSONS FISCHERMcap ₹30.2 Cr

View

	In ₹ Crore except Per Share As of	FY23 31/03/2023
	Non-current Assets
	+ Property, Plant & Equipment	17.3
	+ Capital Work-in-Progress	3.8
	+ Other Intangibles	0.0
	+ Non-current Investments	11.9
	+ Other Non-current Financial Assets	0.1
	Non-current Financial Assets	12.0
	+ Other Non-current Assets	2.4
	Total Non-current Assets	35.7
	Current Assets
	+ Inventories	6.1
	+ Current Investments	0.0
	+ Trade Receivables	4.9
	+ Cash & Cash Equivalents	0.1
	+ Other Bank Balances	0.3
	+ Other Current Financial Assets	1.7
	Current Financial Assets	7.0
	+ Other Current Assets	0.4
	Total Current Assets	13.4
	Total Assets	49.1
	Equity
	+ Equity Share Capital	5.0
	+ Other Equity / Reserves	22.5
	Equity — Owners of Parent	27.5
	Total Equity	27.5
	Liabilities
	+ Borrowings — Non-current	1.2
	+ Other Non-current Financial Liab	1.0
	Non-current Financial Liabilities	2.1
	+ Provisions — Non-current	1.9
	Non-current Liabilities	4.1
	+ Borrowings — Current	10.0
	+ Trade Payables	5.2
	+ Other Current Financial Liab	1.5
	Current Financial Liabilities	16.8
	+ Provisions — Current	0.4
	+ Other Current Liabilities	0.4
	Current Liabilities	17.6
	Total Liabilities	21.6
	Total Equity & Liabilities	49.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY23 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.